Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Rubnitz

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Leukemia|March 13, 2001
Second malignancy after treatment of childhood acute myeloid leukemiaW Leung, R C Ribeiro, M Hudson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaJ G Blanco, T Dervieux, M J Edick, et al.
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
JAMA|November 1, 2000
Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopeniaS C Howard, A Gajjar, R C Ribeiro, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Leukemia|October 3, 2002
Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experienceJ E Rubnitz, S C Raimondi, A R Halbert, et al.
Leukemia|February 27, 2009
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialJ E Rubnitz, K R Crews, S Pounds, et al.
Lancet (London, England)|July 16, 1999
High incidence of secondary brain tumours after radiotherapy and antimetabolitesM V Relling, J E Rubnitz, G K Rivera, et al.
Blood|June 5, 2001
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale, B I Razzouk, S C Raimondi, et al.
Lancet (London, England)|March 11, 1998
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaE Coustan-Smith, F G Behm, J Sanchez, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Leukemia|March 13, 2001
Second malignancy after treatment of childhood acute myeloid leukemiaW Leung, R C Ribeiro, M Hudson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaJ G Blanco, T Dervieux, M J Edick, et al.
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
JAMA|November 1, 2000
Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopeniaS C Howard, A Gajjar, R C Ribeiro, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Leukemia|October 3, 2002
Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experienceJ E Rubnitz, S C Raimondi, A R Halbert, et al.
Leukemia|February 27, 2009
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialJ E Rubnitz, K R Crews, S Pounds, et al.
Lancet (London, England)|July 16, 1999
High incidence of secondary brain tumours after radiotherapy and antimetabolitesM V Relling, J E Rubnitz, G K Rivera, et al.
Blood|June 5, 2001
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale, B I Razzouk, S C Raimondi, et al.
Lancet (London, England)|March 11, 1998
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaE Coustan-Smith, F G Behm, J Sanchez, et al.
Pageof 7